ASHLYN BARTELLO: Open Payments
NPI 1306552526 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 59 payments from 25 companies in 2025. Trend: 2023 $488 · 2024 $550 · 2025 $1,163
Food & beverage: $1,163
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $143 |
| Lilly USA, LLC | 7 | $129 |
| Dexcom, Inc. | 4 | $86 |
| Novo Nordisk Inc | 5 | $84 |
| Lundbeck LLC | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Amgen Inc. | 4 | $64 |
| PFIZER INC. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Esperion Therapeutics, Inc. | 2 | $51 |
Products named: REXULTI, Dexcom G6 Transmitter, FARXIGA, MOUNJARO, BREZTRI, Wegovy, CAPLYTA, NEXLETOL.
Industry payments across GA — which companies pay providers there.
